Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zastaprazan vs Esomeprazole in Erosive Esophagitis
NCT05443984Phase 3Completed
- Sponsor
- Onconic Therapeutics Inc.
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zastaprazan in erosive esophagitis (EE), sponsored by Onconic Therapeutics Inc.. Started Jan 2022; status: completed.
02
Drugs
zastaprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT05443984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05443984.